348 related articles for article (PubMed ID: 32445922)
1. Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene.
Melanitou E
Gene; 2020 Aug; 753():144785. PubMed ID: 32445922
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of osteopontin in type 1 diabetes.
Gong Q; Chipitsyna G; Gray CF; Anandanadesan R; Arafat HA
Islets; 2009; 1(1):34-41. PubMed ID: 21084847
[TBL] [Abstract][Full Text] [Related]
3. Nonobese diabetic congenic strain analysis of autoimmune diabetes reveals genetic complexity of the Idd18 locus and identifies Vav3 as a candidate gene.
Fraser HI; Dendrou CA; Healy B; Rainbow DB; Howlett S; Smink LJ; Gregory S; Steward CA; Todd JA; Peterson LB; Wicker LS
J Immunol; 2010 May; 184(9):5075-84. PubMed ID: 20363978
[TBL] [Abstract][Full Text] [Related]
4. Early over expression of messenger RNA for multiple genes, including insulin, in the Pancreatic Lymph Nodes of NOD mice is associated with Islet Autoimmunity.
Regnault B; Osorio Y Fortea J; Miao D; Eisenbarth G; Melanitou E
BMC Med Genomics; 2009 Oct; 2():63. PubMed ID: 19799787
[TBL] [Abstract][Full Text] [Related]
5. Two genetic loci regulate T cell-dependent islet inflammation and drive autoimmune diabetes pathogenesis.
Fox CJ; Paterson AD; Mortin-Toth SM; Danska JS
Am J Hum Genet; 2000 Jul; 67(1):67-81. PubMed ID: 10848492
[TBL] [Abstract][Full Text] [Related]
6. Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping.
Lyons PA; Armitage N; Argentina F; Denny P; Hill NJ; Lord CJ; Wilusz MB; Peterson LB; Wicker LS; Todd JA
Genome Res; 2000 Apr; 10(4):446-53. PubMed ID: 10779485
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.
Ivakine EA; Fox CJ; Paterson AD; Mortin-Toth SM; Canty A; Walton DS; Aleksa K; Ito S; Danska JS
J Immunol; 2005 Jun; 174(11):7129-40. PubMed ID: 15905556
[TBL] [Abstract][Full Text] [Related]
8. Deletion of 12/15-lipoxygenase alters macrophage and islet function in NOD-Alox15(null) mice, leading to protection against type 1 diabetes development.
Green-Mitchell SM; Tersey SA; Cole BK; Ma K; Kuhn NS; Cunningham TD; Maybee NA; Chakrabarti SK; McDuffie M; Taylor-Fishwick DA; Mirmira RG; Nadler JL; Morris MA
PLoS One; 2013; 8(2):e56763. PubMed ID: 23437231
[TBL] [Abstract][Full Text] [Related]
9. A Reg family protein is overexpressed in islets from a patient with new-onset type 1 diabetes and acts as T-cell autoantigen in NOD mice.
Gurr W; Yavari R; Wen L; Shaw M; Mora C; Christa L; Sherwin RS
Diabetes; 2002 Feb; 51(2):339-46. PubMed ID: 11812740
[TBL] [Abstract][Full Text] [Related]
10. Impact of protective IL-2 allelic variants on CD4+ Foxp3+ regulatory T cell function in situ and resistance to autoimmune diabetes in NOD mice.
Sgouroudis E; Albanese A; Piccirillo CA
J Immunol; 2008 Nov; 181(9):6283-92. PubMed ID: 18941219
[TBL] [Abstract][Full Text] [Related]
11. Streptozotocin (STZ) mediates acute upregulation of serum and pancreatic osteopontin (OPN): a novel islet-protective effect of OPN through inhibition of STZ-induced nitric oxide production.
Katakam AK; Chipitsyna G; Gong Q; Vancha AR; Gabbeta J; Arafat HA
J Endocrinol; 2005 Nov; 187(2):237-47. PubMed ID: 16293771
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-21 is required for the development of type 1 diabetes in NOD mice.
Sutherland AP; Van Belle T; Wurster AL; Suto A; Michaud M; Zhang D; Grusby MJ; von Herrath M
Diabetes; 2009 May; 58(5):1144-55. PubMed ID: 19208913
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
[TBL] [Abstract][Full Text] [Related]
15. Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background.
Bour-Jordan H; Thompson HL; Giampaolo JR; Davini D; Rosenthal W; Bluestone JA
J Autoimmun; 2013 Sep; 45():58-67. PubMed ID: 23850635
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the G6pc2 gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein does not affect the progression or incidence of type 1 diabetes in NOD/ShiLtJ mice.
Oeser JK; Parekh VV; Wang Y; Jegadeesh NK; Sarkar SA; Wong R; Lee CE; Pound LD; Hutton JC; Van Kaer L; O'Brien RM
Diabetes; 2011 Nov; 60(11):2922-7. PubMed ID: 21896930
[TBL] [Abstract][Full Text] [Related]
17. A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice.
Brodnicki TC; Quirk F; Morahan G
Diabetes; 2003 Jan; 52(1):218-22. PubMed ID: 12502517
[TBL] [Abstract][Full Text] [Related]
18. Acceleration of autoimmune diabetes in Rheb-congenic NOD mice with β-cell-specific mTORC1 activation.
Sasaki H; Yasuda H; Moriyama H; Nakamura A; Shimizu M; Arai T; Nagata M; Hara K; Yokono K
Biochem Biophys Res Commun; 2011 May; 408(2):306-11. PubMed ID: 21513702
[TBL] [Abstract][Full Text] [Related]
19. The pro-apoptotic BH3-only protein Bid is dispensable for development of insulitis and diabetes in the non-obese diabetic mouse.
Mollah ZU; Wali J; McKenzie MD; Krishnamurthy B; Graham KL; Fynch S; Szanyi J; Santamaria P; Brodnicki T; Allison J; Strasser A; Kay TW; Thomas HE
Apoptosis; 2011 Aug; 16(8):822-30. PubMed ID: 21644000
[TBL] [Abstract][Full Text] [Related]
20. The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population.
Chiocchetti A; Orilieri E; Cappellano G; Barizzone N; D' Alfonso S; D' Annunzio G; Lorini R; Ravazzolo R; Cadario F; Martinetti M; Calcaterra V; Cerutti F; Bruno G; Larizza D; Dianzani U
Int J Immunopathol Pharmacol; 2010; 23(1):263-9. PubMed ID: 20378012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
